BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 3 hits Enz. Inhib. hit(s) with Target = 'Interleukin-1 receptor-associated kinase 4' and Ligand = 'BDBM403064'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Interleukin-1 receptor-associated kinase 4


(Homo sapiens (Human))
BDBM403064
PNG
(US10329302, Example 216 | US10793579, Example 216 ...)
Show SMILES COc1cc2c(OC[C@H]3NC(=O)C[C@H]3C)cccc2cc1C(N)=O |r|
Show InChI InChI=1S/C18H20N2O4/c1-10-6-17(21)20-14(10)9-24-15-5-3-4-11-7-13(18(19)22)16(23-2)8-12(11)15/h3-5,7-8,10,14H,6,9H2,1-2H3,(H2,19,22)(H,20,21)/t10-,14-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.400n/an/an/an/an/an/a



St. Jude Research Hospital



Assay Description
This is an in vitro assay to measure IRAK4 enzymatic activity utilizing the DELFIA (Dissociation-Enhanced Lanthanide Fluorescent Immunoassay, Perkin-...


ACS Chem Biol 4: 834-43 (2009)


BindingDB Entry DOI: 10.7270/Q2FT8PC5
More data for this
Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4


(Homo sapiens (Human))
BDBM403064
PNG
(US10329302, Example 216 | US10793579, Example 216 ...)
Show SMILES COc1cc2c(OC[C@H]3NC(=O)C[C@H]3C)cccc2cc1C(N)=O |r|
Show InChI InChI=1S/C18H20N2O4/c1-10-6-17(21)20-14(10)9-24-15-5-3-4-11-7-13(18(19)22)16(23-2)8-12(11)15/h3-5,7-8,10,14H,6,9H2,1-2H3,(H2,19,22)(H,20,21)/t10-,14-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
n/an/a 0.400n/an/an/an/an/an/a


TBA



Citation and Details

BindingDB Entry DOI: 10.7270/Q27D308N
More data for this
Ligand-Target Pair
Interleukin-1 receptor-associated kinase 4


(Homo sapiens (Human))
BDBM403064
PNG
(US10329302, Example 216 | US10793579, Example 216 ...)
Show SMILES COc1cc2c(OC[C@H]3NC(=O)C[C@H]3C)cccc2cc1C(N)=O |r|
Show InChI InChI=1S/C18H20N2O4/c1-10-6-17(21)20-14(10)9-24-15-5-3-4-11-7-13(18(19)22)16(23-2)8-12(11)15/h3-5,7-8,10,14H,6,9H2,1-2H3,(H2,19,22)(H,20,21)/t10-,14-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.400n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
Protocol B: To begin the assay, 45 μL of reaction mixture containing 20 mM HEPES pH=7.5, 5 mM MgCl2, 0.0025% Brij-35, 600 μM ATP, 228 μ...


US Patent US10793579 (2020)


BindingDB Entry DOI: 10.7270/Q2H9988P
More data for this
Ligand-Target Pair